The Group's principal activities are to develop, manufacture and market biotechnology products. It operates through four segments: Genetic Diseases which develops, manufactures and distributes therapeutic products. Cardiometabolic and Renal, which develops, manufactures and distributes products that treat patients suffering from renal diseases. Biosurgery, which develops, manufactures and distributes biotherapeutics and biomaterial-based products. Hematologic Oncology, which develops, manufactures and distributes products for the treatment of cancer.
Alacra Alerts:
Receive alerts on the latest reports on Genzyme Corporation
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
